2NAJEAN Y, DREACH C, RAIN J D: The very long term course of polycythemia: a complenent to the previously published date of PVSG[J]. Br J Haematol,1994,86:233.
4CASTELLO G, LERZA R, CERRUTTI D, et al. The in vivtro and in vivo effect of recombinant interferon alpha-2 α on circulating heamatopoietic progenitor cells in polycythemia vera[J]. Br J Haematol, 1994, 87: 621-623.
3Castello G,Lerza R,Cerrutti D,et al.The in vivtro and in vivo effect of recombinant interferon alpha-2αon circulating heematopoietic progenitor cells in polythemia vera.Br J Haematol,1994,87:621-623.
4Falanga A, Marchetti M, Vignoli A, et al. Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol,2005,33 (5) :523.
6Orland E.Hemorrhagic and thrombotic complications in polythemia vera,A clinical study[J].Haematologica,2002,12(8):29.
7VARDIMAN J W, THIELE J, ARBER D A, et al. The 2008 revision of theWorld Health Organization (WHO) classification of myeloid neoplasms and acute leukemia:rationale and important changes[J]. Blood, 2009,114:937-951.
